Final evidence from the WHO Solidarity clinical trials shows that remdesivir has only a slight protective effect and only among certain patients with COVID-19.
Cecelia Koetting, OD, demonstrates a blepharo-exfoliation procedure used to treat patients with Demodex.
Optometrist Sara Weidmayer, OD, and dermatologist Rebecca Baxt, MD, respond to interdisciplinary questions about comanaging ocular and facial rosacea.
Saraschandra Vallabhajosyula, MD, and Ibrahim Sultan, MD, discuss the relationship between the weekend effect and poor prognosis following cardiac emergencies.
We spoke with Susan E. Schindler, MD, PhD, lead author of a study about the effect of race on the prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light.
Courtney Dryer, OD discusses 8 lifestyle changes patients can make to reduce dry eye symptomatology.
David Dickerson, MD, chair of the ASA Committee on Pain Medicine, discusses suggested changes and recommendations to the proposed clinical practice guidelines for prescribing opioids that were recently issued by the CDC.
In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
Paul Harris, OD, David Meltzer, OD, and Katherine Weise, OD address athletic eye safety concerns, and how optometrists can coach their patients.